Evidence map›Paper›PMID 24488492›Full record

ArticleThe Journal of biological chemistry2014

The methyltransferase WBSCR22/Merm1 enhances glucocorticoid receptor function and is regulated in lung inflammation and cancer.

Maryam Jangani, Toryn M Poolman, Laura Matthews, Nan Yang, Stuart N Farrow, Andrew Berry, Neil Hanley, Andrew J K Williamson, Anthony D Whetton, Rachelle Donn and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Integrated DNA methylation analysis reveals a potential role for ANKRD30B in Williams syndrome.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2020
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Maryam JanganiFrom the Centre in Endocrinology and Diabetes, Institute of Human Development, and.
Toryn M Poolman
Laura Matthews
Nan Yang
Stuart N Farrow
Andrew Berry
Neil Hanley
Andrew J K Williamson
Anthony D Whetton
Rachelle Donn
David W Ray
University of Manchester · GBManchester Academic Health Science Centre · GBDiabetes Australia · AU

Funding

Biotechnology and Biological Sciences Research CouncilMedical Research Council MR/K015885/1Medical Research Council MR/L00254X/1Medical Research Council MR/L010240/1Wellcome Trust 088566Wellcome Trust 097820
6 · The paper itself

Abstract

Glucocorticoids (GC) regulate cell fate and immune function. We identified the metastasis-promoting methyltransferase, metastasis-related methyltransferase 1 (WBSCR22/Merm1) as a novel glucocorticoid receptor (GR) regulator relevant to human disease. Merm1 binds the GR co-activator GRIP1 but not GR. Loss of Merm1 impaired both GR transactivation and transrepression by reducing GR recruitment to its binding sites. This was accompanied by loss of GR-dependent H3K4Me3 at a well characterized promoter. Inflammation promotes GC resistance, in part through the actions of TNFα and IFNγ. These cytokines suppressed Merm1 protein expression by driving ubiquitination of two conserved lysine residues. Restoration of Merm1 expression rescued GR transactivation. Cytokine suppression of Merm1 and of GR function was also seen in human lung explants. In addition, striking loss of Merm1 protein was observed in both inflammatory and neoplastic human lung pathologies. In conclusion, Merm1 is a novel regulator of chromatin structure affecting GR recruitment and function, contributing to loss of GC sensitivity in inflammation, with suppressed expression in pulmonary disease.

Indexed as

B-LymphocytesBronchiCD8-Positive T-LymphocytesCell Line, TumorChromatin Assembly and DisassemblyEpitheliumGene Expression Regulation, NeoplasticGlucocorticoidsHistonesHumansInflammationInterferon-gammaLung NeoplasmsLysineMethylationMethyltransferasesBUD23 protein, humanGlucocorticoidsHistonesInterferon-gammaLysineMethyltransferasesProtein KinasesReceptors, GlucocorticoidRNA, MessengerTumor Necrosis Factor-alphaGlucocorticoid ReceptorGlucocorticoidsHistone MethylationInflammationInterferonLungTumor Necrosis Factor (TNF)Ubiquitination

Identifiers

PMID24488492
PMCPMC3979408
OpenAlexW2130469615

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.